To clarify the role of Trem2 in β-amyloid-driven AD models, we studied the effects of Trem2 deletion on microglial activation, plaque accumulation, and neuronal pathology in the PS2APP model across a wide range of ages and in both sexes. Here, TREM2 is linked to Alzheimer disease.